Skip to main content
STESTERIS plc (Ireland)Hold5.8·$207.17+1.95%
STE · Concentration risk · 10-K extracted

STERIS plc (Ireland) (STE) concentration risks

Updated

The most significant concentration STERIS plc (Ireland) discloses is ethylene oxide and cobalt-60, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: STERIS plc (Ireland)’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 1 disclosed concentration

HIGH1
MEDIUM0
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHOutside partySupplier

ethylene oxide and cobalt-60

10-K Item 1: 'single-sourced in certain regions of the world, such as ethylene oxide ("EO") and radioisotope cobalt-60 ("cobalt-60"), which are necessary to our AST operations'
SEC 10-K · filed May 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-06-24

The company's disclosed concentration is a single, high-share supplier dependency: ethylene oxide and radioisotope cobalt-60 are single-sourced in certain regions of the world, and both are necessary to the company's Applied Sterilization Technologies (AST) operations. By disclosed size this is a large-share exposure, and its character is dependency — the company does not control the production of these inputs, and no disclosed alternative source is available in the affected regions. Ethylene oxide and cobalt-60 are specialty industrial inputs with limited global production capacity, making them inherently difficult to substitute quickly if a single-source supplier experiences a disruption. The nature of cobalt-60 in particular introduces an additional dimension: it is a radioisotope whose supply is tied to the operating status and refueling cycles of specific nuclear reactors, a supply constraint that is geopolitically and logistically complex to resolve. Ethylene oxide carries its own regulatory and safety considerations that constrain where and how it can be produced, stored, and transported. Both inputs are essential to sterilization services for medical devices and pharmaceutical products, so any sustained supply disruption would directly affect AST segment revenue and the company's ability to serve customers reliant on these sterilization methods. No customer, geographic, or product-line concentration is disclosed beyond this supplier dependency. On balance, the concentration profile is narrow in scope but meaningful in impact potential: a single high-share sourcing dependency in specialty inputs that are essential to a core service offering and difficult to replace quickly.

For the engine’s reasoning on STE’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Devices

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
AORTArtivion, Inc.4408
ATECAlphatec Holdings, Inc.1102
ABTAbbott Laboratories1001
STESTERIS plc (Ireland)1001
AXGNAxoGen, Inc.0000
BIOBio-Rad Laboratories, Inc.0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks STE Concentration risk